SCHEMBL8269147

SCHEMBL8269147

CC(=O)CNC(=O)c1ccc(CN)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.59
HDAC3 O15379 1/20 0.59
NCOR2 Q9Y618 1/20 0.59
LOXL2 Q9Y4K0 1/20 0.53
MCHR1 Q99705 1/20 0.50
KDM4E B2RXH2 2/20 0.47
MAPT P10636 1/20 0.47
HIF1A Q16665 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
TPSAB1 Q15661 3/20 0.46
HDAC1 Q13547 1/20 0.45
SMYD3 Q9H7B4 1/20 0.44
EPHX2 P34913 3/20 0.44
NR1H4 Q96RI1 2/20 0.44
ITGB3 P05106 1/20 0.43
ITGA2B P08514 1/20 0.43
SPHK2 Q9NRA0 1/20 0.43
MLLT1 Q03111 1/20 0.43
CA1 P00915 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13203130 0.87 KDM4E (0.53) HDAC6KDM4EMAPTHIF1ASLC22A6
SCHEMBL13009911 0.85 HDAC6 (0.68) HDAC6HDAC3NCOR2LOXL2MCHR1
SCHEMBL19634406 0.84 KDM4E (0.68) HDAC6HDAC3NCOR2LOXL2MCHR1
SCHEMBL19634418 0.84 HDAC3 (0.61) HDAC6HDAC3NCOR2LOXL2MCHR1
SCHEMBL21133441 0.83 TAAR1 (0.47) KDM4EMAPTHIF1ASLC22A6SLC22A8
SCHEMBL8269151 0.83 HDAC3 (0.56) HDAC6HDAC3NCOR2LOXL2MCHR1
SCHEMBL5855594 0.82 HDAC1 (0.45) HDAC6KDM4EMAPTHIF1ASLC22A6
SCHEMBL13113151 0.81 MAPT (0.70) HDAC6HDAC3KDM4EMAPTHIF1A
SCHEMBL13461011 0.81 HDAC3 (0.63) HDAC6HDAC3NCOR2LOXL2MCHR1
SCHEMBL19634398 0.81 HDAC3 (0.54) HDAC6HDAC3NCOR2LOXL2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040014763-A1 beta-sheet mimetics and composition and methods relating thereto MYRIAD PHARMACEUTICALS, INC. (US) 2004-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014763-A1 beta-sheet mimetics and composition and methods relating thereto TPSAB1, TPSB2, TPSD1 HDAC6 2054/4885HDAC3 3559/4885NCOR2 4819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.